Voltage-dependent L-type calcium channel (Cav1) (Cav1)

Voltage-dependent L-type calcium channels (Cav1.x) are a family of high-voltage activated ion channels that mediate the influx of calcium ions into cells in response to membrane depolarization [1.2.1, 1.2.4]. This family includes four distinct subtypes—Cav1.1, Cav1.2, Cav1.3, and Cav1.4—which are expressed in various tissues including skeletal muscle, cardiac muscle, smooth muscle, neurons, and endocrine cells [1.1.1, 1.2.5]. They are essential for critical physiological processes such as excitation-contraction coupling, hormone secretion, neurotransmitter release, and gene expression [1.2.1, 1.2.3]. The Cav1.x channels are famously characterized by their high sensitivity to dihydropyridine (DHP) class drugs, which act as potent inhibitors [1.2.1, 1.2.4]. Mutations or dysregulation of these channels are linked to a variety of "channelopathies," including cardiovascular disorders like hypertension and arrhythmias, as well as neuropsychiatric conditions like bipolar disorder and autism [1.3.2, 1.3.3, 1.4.2]. Clinically, L-type calcium channel blockers (CCBs) are widely used to treat hypertension and angina by promoting vasodilation and reducing cardiac workload [1.2.1, 1.4.1]. Beyond cardiovascular health, these channels are increasingly recognized for their roles in neurodegeneration and cancer progression, highlighting their importance as multi-organ therapeutic targets [1.3.1, 1.4.5]. Their complex structure, consisting of a pore-forming alpha-1 subunit and several auxiliary subunits, allows for fine-tuned regulation of calcium signaling across different cell types [1.2.1, 1.2.3].

Other names

L-type calcium channelLTCCDihydropyridine receptorDHPRHigh-voltage activated calcium channelHVA calcium channelCav1 family

L-type calcium channel blockers bind to the alpha-1 subunit of the channel complex, stabilizing it in the closed or inactive state. This action inhibits the influx of calcium ions into the cytoplasm during membrane depolarization, which in turn reduces calcium-induced calcium release from the sarcoplasmic reticulum, leading to decreased muscle contractility and vascular smooth muscle relaxation [1.2.1, 1.2.4].